Drugs watchdog NICE attacks pharmaceutical industry in pricing dispute

The Times

25 September 2017 - Industry expert’s evidence is not independent, NICE argues.

The credibility of an expert witness put up by the pharmaceuticals industry has been shot down by a NHS watchdog in a legal row over drugs pricing.

Court papers obtained by The Times show that NICE has dismissed evidence from drugs companies as “plainly not independent”.

Read The Times article

Michael Wonder

Posted by:

Michael Wonder